The bill enacts R.S. 37:1218.2, which authorizes pharmacists in Louisiana to dispense human immunodeficiency virus (HIV) pre-exposure and post-exposure prophylaxis without a prescription for individuals aged seventeen and older. It mandates that pharmacists complete a training program approved by the Louisiana Department of Health, which will also be responsible for promulgating rules to implement these provisions. The training will cover various aspects, including financial assistance programs and strategies for accessing resources to ensure equitable care for patients regardless of their insurance status. Additionally, pharmacists are required to perform rapid HIV tests and maintain patient confidentiality.

The Louisiana Department of Health is tasked with creating administrative rules by March 2025, which will include requirements for testing, screening, and treatment protocols. The rules will also outline the reimbursement process for pharmacists, ensuring they are compensated at the same rate as other healthcare providers for these services. However, the bill clarifies that it does not obligate health coverage plans or third-party administrators to reimburse pharmacists as in-network or preferred providers. Overall, the legislation aims to enhance access to HIV prevention and treatment services through community pharmacies.